Cargando…

Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults

OBJECTIVES: To assess the prevalence of sarcopenic obesity and its association with functionality, lifestyle, biomarkers, and morbidities in older adults. METHODS: The study analyzed cross-sectional data from 270 older adults who participated in phase III of the Frailty in Brazilian Older People Stu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Campos, Glaucia Cristina, Lourenço, Roberto Alves, Lopes, Claudia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688075/
https://www.ncbi.nlm.nih.gov/pubmed/33263630
http://dx.doi.org/10.6061/clinics/2020/e1814
_version_ 1783613638426230784
author de Campos, Glaucia Cristina
Lourenço, Roberto Alves
Lopes, Claudia S.
author_facet de Campos, Glaucia Cristina
Lourenço, Roberto Alves
Lopes, Claudia S.
author_sort de Campos, Glaucia Cristina
collection PubMed
description OBJECTIVES: To assess the prevalence of sarcopenic obesity and its association with functionality, lifestyle, biomarkers, and morbidities in older adults. METHODS: The study analyzed cross-sectional data from 270 older adults who participated in phase III of the Frailty in Brazilian Older People Study (Fragilidade em Idosos Brasileiros—Rio de Janeiro, FIBRA-RJ study-2013). They took part in a home interview surveying socioeconomic, demographic, lifestyle, morbidities, and functional data. Blood was collected for biochemical marker analysis and participants’ body composition was determined by dual-energy X-ray absorptiometry. For women, the diagnosis of sarcopenic obesity was defined at a body fat percentage ≥38% and appendicular skeletal muscle mass index (ASMMI) <5.45 kg/m(2). For men, a fat percentage ≥27% and ASMMI <7.26 kg/m(2) was defined as sarcopenic obesity. Multivariate analysis was performed using a multinomial regression model (95% confidence intervals), with sarcopenic obesity as the outcome. RESULTS: The prevalence of sarcopenic obesity was 29.3%. In the final fitted model, the variables that displayed statistically significant association with sarcopenic obesity were lower gait speed, self-reported medical diagnosis of arthrosis or arthritis, and high levels of glycemia. CONCLUSION: The study showed a high prevalence of sarcopenic obesity in non-institutionalized older adults in Brazil. The finding that this condition was associated with modifiable risk factors may provide insights into measures directed at prevention and reduction of the risk of sarcopenic obesity in this population subgroup.
format Online
Article
Text
id pubmed-7688075
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Faculdade de Medicina / USP
record_format MEDLINE/PubMed
spelling pubmed-76880752020-11-26 Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults de Campos, Glaucia Cristina Lourenço, Roberto Alves Lopes, Claudia S. Clinics (Sao Paulo) Original Article OBJECTIVES: To assess the prevalence of sarcopenic obesity and its association with functionality, lifestyle, biomarkers, and morbidities in older adults. METHODS: The study analyzed cross-sectional data from 270 older adults who participated in phase III of the Frailty in Brazilian Older People Study (Fragilidade em Idosos Brasileiros—Rio de Janeiro, FIBRA-RJ study-2013). They took part in a home interview surveying socioeconomic, demographic, lifestyle, morbidities, and functional data. Blood was collected for biochemical marker analysis and participants’ body composition was determined by dual-energy X-ray absorptiometry. For women, the diagnosis of sarcopenic obesity was defined at a body fat percentage ≥38% and appendicular skeletal muscle mass index (ASMMI) <5.45 kg/m(2). For men, a fat percentage ≥27% and ASMMI <7.26 kg/m(2) was defined as sarcopenic obesity. Multivariate analysis was performed using a multinomial regression model (95% confidence intervals), with sarcopenic obesity as the outcome. RESULTS: The prevalence of sarcopenic obesity was 29.3%. In the final fitted model, the variables that displayed statistically significant association with sarcopenic obesity were lower gait speed, self-reported medical diagnosis of arthrosis or arthritis, and high levels of glycemia. CONCLUSION: The study showed a high prevalence of sarcopenic obesity in non-institutionalized older adults in Brazil. The finding that this condition was associated with modifiable risk factors may provide insights into measures directed at prevention and reduction of the risk of sarcopenic obesity in this population subgroup. Faculdade de Medicina / USP 2020-11-25 2020 /pmc/articles/PMC7688075/ /pubmed/33263630 http://dx.doi.org/10.6061/clinics/2020/e1814 Text en Copyright © 2020 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Original Article
de Campos, Glaucia Cristina
Lourenço, Roberto Alves
Lopes, Claudia S.
Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults
title Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults
title_full Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults
title_fullStr Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults
title_full_unstemmed Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults
title_short Prevalence of Sarcopenic Obesity and its Association with Functionality, Lifestyle, Biomarkers and Morbidities in Older Adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults
title_sort prevalence of sarcopenic obesity and its association with functionality, lifestyle, biomarkers and morbidities in older adults: the fibra-rj study of frailty in older brazilian adults
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688075/
https://www.ncbi.nlm.nih.gov/pubmed/33263630
http://dx.doi.org/10.6061/clinics/2020/e1814
work_keys_str_mv AT decamposglauciacristina prevalenceofsarcopenicobesityanditsassociationwithfunctionalitylifestylebiomarkersandmorbiditiesinolderadultsthefibrarjstudyoffrailtyinolderbrazilianadults
AT lourencorobertoalves prevalenceofsarcopenicobesityanditsassociationwithfunctionalitylifestylebiomarkersandmorbiditiesinolderadultsthefibrarjstudyoffrailtyinolderbrazilianadults
AT lopesclaudias prevalenceofsarcopenicobesityanditsassociationwithfunctionalitylifestylebiomarkersandmorbiditiesinolderadultsthefibrarjstudyoffrailtyinolderbrazilianadults